The transcription factor Tbet is critical for the differentiation of Th1 CD4 T cells and is associated with the induction of multiple autoimmune diseases, including experimental autoimmune encephalomyelitis (EAE). Herein, we demonstrate that Tbet suppresses IL-17A and Th17 differentiation both in vitro and in vivo in a cell-intrinsic manner, and that in fact, Tbet is not necessary for EAE induction. Moreover, we find that IFNγ inhibits the production of IL-17A and IL-17F in a STAT1-dependent, Tbet-independent manner. These findings illustrate multiple mechanisms utilized by developing Th1 cells to silence the Th17 program.
Introduction
Experimental autoimmune encephalomyelitis (EAE) is a mouse model for multiple sclerosis (MS), with similar pathology including elevated levels of the cytokines IFNγ and IL-17A in the CNS (Goverman, 2009; Fletcher et al., 2010) . CD4 T cells play an essential role during EAE in which MOG peptide elicits robust CD4 T cell responses; in addition, myelin specific CD4 T cells are able to drive disease in naïve mice (Bettelli et al., 2004) . Both Th1 and Th17 subsets are pathogenic populations during EAE; however, mice deficient in the signature cytokines IFNγ, IL-17A, or IL-17F are not protected from disease (Ferber et al., 1996; Bettelli et al., 2004; Hofstetter et al., 2005; Komiyama et al., 2006; Gonzalez-Garcia et al., 2009; Hu et al., 2010) . Hence, the regulation and mechanism of how effector CD4 T cell subsets drive EAE remain ill-defined.
Tbet, abbreviated from T-box expressed in T cells, is expressed by a number of hematopoietic cells and is essential to initiate the gene expression program during Th1 differentiation (Szabo et al., 2002; Lazarevic and Glimcher, 2011) . In addition, CD4 T cells deficient in Tbet tend to develop into either Th2 or Th17 populations depending on the stimulation conditions, indicating the suppressive property of Tbet on other lineages (Finotto et al., 2002; Lazarevic et al., 2011) . During Th1 differentiation, Tbet has been reported to be phosphorylated by IL-2-inducible T-cell kinase that enables Tbet to interact with GATA-3 and inhibit Th2 differentiation (Miller et al., 2004) . Likewise, Tbet is capable of suppressing Th17 development by hijacking Runx1 which promotes expression of the Th17 master transcription factor, RORγt (Lazarevic et al., 2011) . Thus, Tbet functions at multiple levels to cement the Th1 differentiation program and extinguish alternative effector cell fates.
CD4 T cells are critical for the development of multiple autoimmune disorders and expression of Tbet has also been shown to be mandatory for the pathogenesis associated with certain autoimmune diseases (Goverman, 2009; Zenewicz et al., 2009; Alzabin and Williams, 2011; Haskins and Cooke, 2011) . Paradoxically, while it is reported that Tbet is necessary for EAE induction (Bettelli et al., 2004) , it has also been demonstrated that this molecule can suppress Th17 differentiation (Lazarevic et al., 2011) , a key cell population linked with the development of EAE. It remains unclear how Tbet drives CNS inflammation and if expression of this molecule is required within the Th17 population. Interestingly, a fraction of the effector CD4 T cells isolated from the inflamed CNS during EAE are capable of producing both IFNγ and IL-17A, and these cells also express Tbet (Yeh et al., 2011) . It is thought that this population is a consequence of Th17 plasticity, and, in recent years, a number of publications have correlated the presence of this cell population with the severity of disease (Ghoreschi et al., 2010; Hirota et al., 2011) .
The importance of Tbet within CD4 T cells during EAE is still not understood. In this study, we investigated the function of this transcription factor in CD4 T cells and show that it was not required for the migration of the cells to the inflamed CNS, and contrary to published reports, we did not observe a requirement for Tbet in the development of EAE. In addition, we demonstrate that Tbet actively suppressed not only IL-17A production, but also differentiation of Th17 cells by limiting the expression of the master transcription factor RORγt. It is known that IFNγ can suppress Th17 differentiation and here we reveal that it signals through STAT1 to mediate this effect. Interestingly, IFNγ inhibition of RORγt requires the expression of Tbet, however IFNγ can still repress IL-17A and
